fda approval for tirzepatide Wins Weight Loss Exploring Tirzepatide: A Revolutionary Approach

Even pregnant or nursing women must avoid it, as there is no safety data for this group

Eli Lillys retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, remains in Phase 3 TRIUMPH trials as of mid-2026, with NDA submission projected no earlier than Q4 2026

One user found her dizziness only occurred when she took her injection after 7pm

Research has shown that Vita Carnitine stimulates the use of fat for fuel and boosts metabolism, which plays a key role in weight management

Choline: part of the B vitamin family, it breaks down fat, keeps cell membranes healthy and helps prevent gallstones

Morning glutathione and evening semaglutide, or vice versa, optimizes both compounds' therapeutic effect